Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2015 3
2016 2
2017 3
2019 4
2020 2
2021 1
2023 3
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
New generation anaplastic lymphoma kinase inhibitors.
Delmonte A, Burgio MA, Verlicchi A, Bronte G, Cravero P, Ulivi P, Martinelli G, Crinò L. Delmonte A, et al. Among authors: verlicchi a. Transl Lung Cancer Res. 2019 Nov;8(Suppl 3):S280-S289. doi: 10.21037/tlcr.2019.09.14. Transl Lung Cancer Res. 2019. PMID: 31857951 Free PMC article. Review.
HER3 as a Therapeutic Target in Cancer.
Karachaliou N, Lazzari C, Verlicchi A, Sosa AE, Rosell R. Karachaliou N, et al. Among authors: verlicchi a. BioDrugs. 2017 Feb;31(1):63-73. doi: 10.1007/s40259-016-0205-2. BioDrugs. 2017. PMID: 28000159 Review.
Targeting RET-rearranged non-small-cell lung cancer: future prospects.
Bronte G, Ulivi P, Verlicchi A, Cravero P, Delmonte A, Crinò L. Bronte G, et al. Among authors: verlicchi a. Lung Cancer (Auckl). 2019 Mar 20;10:27-36. doi: 10.2147/LCTT.S192830. eCollection 2019. Lung Cancer (Auckl). 2019. PMID: 30962732 Free PMC article. Review.
Cancer stem cells in small cell lung cancer.
Codony-Servat J, Verlicchi A, Rosell R. Codony-Servat J, et al. Among authors: verlicchi a. Transl Lung Cancer Res. 2016 Feb;5(1):16-25. doi: 10.3978/j.issn.2218-6751.2016.01.01. Transl Lung Cancer Res. 2016. PMID: 26958490 Free PMC article. Review.
Second-line therapy of squamous non-small cell lung cancer: an evolving landscape.
Lazzari C, Karachaliou N, Gregorc V, Bulotta A, Gonzalez-Cao M, Verlicchi A, Altavilla G, Rosell R, Santarpia M. Lazzari C, et al. Among authors: verlicchi a. Expert Rev Respir Med. 2017 Jun;11(6):469-479. doi: 10.1080/17476348.2017.1326822. Epub 2017 May 15. Expert Rev Respir Med. 2017. PMID: 28467720 Review.
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience.
Andrikou K, Ulivi P, Petracci E, Azzali I, Bertolini F, Alberti G, Bettelli S, Calistri D, Chiadini E, Capelli L, Cravero P, Guaitoli G, Zanelli F, Burgio MA, Pagano M, Verlicchi A, Martinelli E, Di Emidio K, Dominici M, Pinto C, Delmonte A. Andrikou K, et al. Among authors: verlicchi a. Diagnostics (Basel). 2024 May 15;14(10):1024. doi: 10.3390/diagnostics14101024. Diagnostics (Basel). 2024. PMID: 38786322 Free PMC article.
Author Correction: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.
Karachaliou N, Codony-Servat J, Teixidó C, Pilotto S, Drozdowskyj A, Codony-Servat C, Giménez-Capitán A, Molina-Vila MA, Bertrán-Alamillo J, Gervais R, Massuti B, Morán T, Majem M, Felip E, Carcereny E, García-Campelo R, Viteri S, González-Cao M, Morales-Espinosa D, Verlicchi A, Crisetti E, Chaib I, Santarpia M, Luis Ramírez J, Bosch-Barrera J, Felipe Cardona A, de Marinis F, López-Vivanco G, Miguel Sánchez J, Vergnenegre A, Sánchez Hernández JJ, Sperduti I, Bria E, Rosell R. Karachaliou N, et al. Among authors: verlicchi a. Sci Rep. 2023 Mar 3;13(1):3620. doi: 10.1038/s41598-023-30374-9. Sci Rep. 2023. PMID: 36869103 Free PMC article. No abstract available.
21 results